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Introduction
Current data indicate that approximately 185 million people worldwide have been infected with hepatitis C virus (HCV), and that around 350,000
deaths occur each year due to all HCV-related causes. 1 HCV infections account for a quarter of the cases of cirrhosis and primary liver cancer, 2 Injection drug users (IDUs) are responsible for a major international public health problem, and they remain the largest group of persons infected with HCV. 4 Estimates indicate that there are about 16 million individuals who inject drugs worldwide, 5 and unsafe drug paraphernalia is the main agent of virus transmission among users. Between 14 and 21 million people (0.3-0.5% of the population aged 15-64 years) are cocaine users. 6 Studies suggest that 10 million people who inject drugs are HCV-infected worldwide, 7 reflecting the high prevalence of these comorbidities.
Prevalence of HCV infection among non-injection
drug users (NIDU), in turn, is much higher than in the general population. 8, 9 HCV infection is more likely among older individuals and those with tattoos -factors previously associated with HCV infection -, and among those who share crack inhalation implements, 8 probably because of the presence of HCV in intranasal drug users' nasal secretions. 10 To facilitate evidence-based policymaking and promote better treatments, it is essential to estimate the impact of HCV infection in different populations, e.g., cocaine users. Our objective is to propose a review of HCV infection patterns among cocaine users. For that, it is important to understand the immunobiological changes that drugs cause in cells compromised by hepatitis, differentiate usage patterns and behavior among IDUs and NIDUs, and finally propose prevention strategies for this group of patients. 25 When we consider only cocaine, in rats, chronic cocaine administration increased IL-10 and TNF-α production and had no effect on IL-1 and IFN-γ production. 
HCV and cocaine immune system

HCV and injecting cocaine use
The most common documented route of HCV infection is through blood transfusions without previous screening and by sharing syringes among IDUs.
27,28
Therefore, injecting cocaine users, similarly to other One study with cocaine users found that injecting cocaine users are more likely to have HCV infection than those who deny injection practice. 32 Similarly to general IDUs, higher family income, tattooing, sharing drug paraphernalia, history of drug use for more than 5 years, and daily use of substances of abuse were risk factors to HCV infection among cocaine users. 32 There is also evidence that the sharing of materials for injection other than syringes/needles, like filters and rinse water, contribute substantially to the spread of hepatitis C among IDUs.
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Genotypes 1a and 3a predominate among IDUs, with genotype 3a being far more frequent in IDUs than in the general population. 35, 36 In a study with Brazilian cocaine users, subtype 1 was most frequently found in the sample (73.3%), although genotype 3 was also found (26.7%), especially in injecting cocaine users (13.3%). 32 It is assumed that the presence of different genotypes can be due to characteristics such as the geography from which the infection was contracted, type of drug used (injectable or non-injectable), and multiple exposures to HCV infections. Genotype 3, for instance, is more common in European populations.
When comparing cocaine injection among heroindependent volunteers, participants who had injected cocaine during the previous month had a nine-fold greater risk of being HCV-positive compared to noncocaine users and those who used cocaine by a noninjecting route.
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In this same sample, the more frequently the participant used cocaine during the previous month, the greater their risk of being HCVpositive. This highlights the need for special care in relation to HCV in the primary attention of drug users when they also consume cocaine. 
HCV and non-injecting cocaine use
Research has mainly focused on injection drug use, but non-injecting cocaine users are also at greater risk of HCV infection. 46 Several studies have reported higher HCV infection in this group in comparison to the general population, particularly among crack cocaine users.
8,47
HCV prevalence among crack users varies greatly, from 1.4% 48 to around 50%. 36 Intranasal cocaine users are not considered a risk group per se, but they could hide a route of parenteral virus spread. 49 Even taking into account that some of them may not have reported drug injection in the past, HCV prevalence is higher than expected. 8 Therefore, other potential HCV infection routes have been suggested among non-injecting cocaine users.
Sharing non-injection drug use paraphernalia is a plausible route for HCV transmission in this population. Tattooing and piercing as risk factors for HCV infection have conflicting findings in the literature. 66 The increase in risk infection seems to be related to highrisk groups, when tattoos are applied in prison settings or by friends 66 -both practices are commonplace among drug users. 54 In addition, drug users are more likely not to receive tattoos or piercings in professional parlors, and the prevalence of these characteristics can reach more than 30% for tattoos and more than 40%
for piercings.
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Collectively, these findings suggest that these nonparenteral routes of HCV infection add a small risk each one. Nonetheless, non-injecting cocaine users are exposed to multiple high-risk situations, placing them in a major group of risk.
Prevention
Many countries in Europe may not yet have invested sufficiently in studies or surveillance systems to guide HCV treatment and prevention policies for IDUs. 68, 69 In other countries, such as Canada, decreases in HCV incidence were accompanied by increases in crack cocaine smoking, and decreases in syringe borrowing coincided with a scale-up of harm reduction programs. 70 Despite the progress made in the development of HCV vaccines, 71 we still do not have an effective vaccine. Primary prevention against hepatitis C focuses on reducing risks of infection through safe injections, and blood safety remains the best alternative to reduce morbidity and mortality. 
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When overlooking these high-risk groups, evidence suggests a high prevalence of comorbidities among drug users with HCV. 76 In this sense, suicide ideation, psychological morbidity and other psychiatric symptoms have been shown to be associated with HCV status and with IFN-α treatment. 75 In fact, suicide was the second most reported cause of death among a sample of HCVpositive drug users in a 33-year follow-up study. Hepatitis C prevention counselling and education are intended to increase knowledge of the disease, clarify perceptions about vulnerability to infection, and increase personal capacity for undertaking safer behaviors. As with syringe sharing, the sharing of drug preparation equipment was associated with lower perceived benefits of safer injecting but also with low self-efficacy to convince others to inject more safely.
Interventions should aim to heighten awareness of the benefits of risk reduction, and to provide IDUs with the skills necessary to negotiate safer injection practices with their peers. 79 Among illicit drug users attending inner city clinics in Canada, studies have observed a low uptake of HCV treatment, but a high willingness to receive therapy. Other risk behaviors for contamination, like unprotected sex and tattooing, are also highly observed in this population. It is also important to consider that the use of cocaine leads to considerable immunosuppression, which also favors viral infections.
Specific impairments in the immune system caused by cocaine use, such as an increased expression of NF-κB, are also linked with HCV infection susceptibility, persistence and increased pathological effects. When we take this evidence into account, it seems apparent that cocaine users are a major risk group for HCV contamination. However, more studies are necessary in order to understand the specific risk factors of cocaine consumption in regards to HCV.
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